Home › SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes
 

Keywords :   


SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes

2015-02-04 06:58:30| drugdiscoveryonline Home Page

SinuSys Corp., an innovative sinus health company, recently announced commencement of a new clinical trial studying its proprietary drug-eluting spacer infused with steroids for use following functional endoscopic sinus surgery (FESS)

Tags: support designed study improve

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »